A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity.


CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks.


We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem.


"],"link":[0,{"title":[0,"Find out more"],"url":[0,"/equitable-access"],"theme":[0,null]}],"textPosition":[0,"left"]}],[0,{"id":[0,"5609"],"type":[0,"block\_media"],"subParagraphType":[0,"media"],"media":[0,{"mediaVideo":[0,null],"mediaLottie":[0,{"url":[0,"/2024-02/CEPI-Dots-BM-01-1.json"]}],"mediaRemoteVideo":[0,null],"mediaImage":[0,null]}]}]]],"textPosition":[0,"left"],"hasTopSwoosh":[0,null],"topRightGraphic":[0,false],"bottomLeftGraphic":[0,null],"decorateTextContent":[0,null],"hasBackgroundGraphic":[0,true],"hasEncircledImage":[0,false],"className":[0,null],"type":[0,"basic\_content\_block"]}],[0,{"id":[0,"4266"],"theme":[0,"themeWhite"],"mediaImage":[0,{"src":[0,"/2023-12/Health-leaders-with-COVAX-signs\_creditUnicef\_1440x810.jpg"],"alt":[0,"A group of health leaders with face covering holding up up signs containing the logo for COVAX, CEPI, GAVI, Unicef, Organisation mondiale de la Sante and ACT accelerator"],"width":[0,null],"height":[0,null]}],"mediaVideo":[0,null],"mediaLottie":[0,null],"mediaRemoteVideo":[0,null],"coupledWith":[0,"CoupledAboveBelow"],"isFullWidth":[0,true],"caption":[0,null],"type":[0,"block\_media\_full"]}],[0,{"id":[0,"4265"],"theme":[0,"themeWhite"],"title":[0,"Where to go next"],"cards":[1,[[0,{"paragraphProps":[0,{"article":[0,null],"external":[0,{"title":[0,"Call for proposals - Bundibugyo Virus vaccines"],"summary":[0,""],"url":[0,"https://cepi.my.site.com/call-for-proposal?id=a1zP3000008XbgvIAC"],"image":[0,null]}],"buttonTheme":[0,"themeCoral"]}]}],[0,{"paragraphProps":[0,{"article":[0,null],"external":[0,{"title":[0,"Careers"],"summary":[0,"Do you want to join a talented team who are passionate about creating a future where epidemics and pandemics are no longer a threat to humanity? "],"url":[0,"/careers"],"image":[0,{"src":[0,"/2023-12/CEPI-staff-groupshot-2022\_1440x810.jpg"],"alt":[0,"A group photo of all the staff at CEPI taken from a bird's eyeview"],"width":[0,null],"height":[0,null]}]}],"buttonTheme":[0,"themeCoral"]}]}],[0,{"paragraphProps":[0,{"article":[0,null],"external":[0,{"title":[0,"Procurement tenders"],"summary":[0,"From time to time, we publish tenders for operational support of our work. "],"url":[0,"/procurement-tenders"],"image":[0,{"src":[0,"/2024-02/cells-with-blue-border-transparent-underwater\_1440x810\_blue-filter.jpg"],"alt":[0,"cells with blue border transparent underwater"],"width":[0,null],"height":[0,null]}]}],"buttonTheme":[0,"themeCoral"]}]}],[0,{"paragraphProps":[0,{"article":[0,null],"external":[0,{"title":[0,"Priority pathogens"],"summary":[0,"CEPI supports the development of vaccines, platform technologies and manufacturing innovations to combat priority pathogens for which no licensed vaccines are currently available."],"url":[0,"/priority-pathogens"],"image":[0,{"src":[0,"/2024-02/Lassa-fever-virus-closeup.jpg"],"alt":[0,"Scanning electron micrograph of Lassa virus budding off a cell"],"width":[0,null],"height":[0,null]}]}],"buttonTheme":[0,"themeCoral"]}]}]]],"type":[0,"spotlight\_links"]}],[0,{"id":[0,"16330"],"linkedInLink":[0,null],"image":[0,{"src":[0,"/2023-12/Vaccine-manufacturing\_1440x810\_blue-filter.png"],"alt":[0,"Lines of vaccines on a conveyor belt in a manufacturing laboratory"],"width":[0,null],"height":[0,null]}],"termsLink":[0,"https://cepi.net/data-protection-and-privacy-policy"],"twitterLink":[0,null],"type":[0,"newsletter"],"theme":[0,"themeBlue"],"facebookLink":[0,null]}]]],"whereNext":[0],"relatedArticles":[1,[]],"mediaContactBlocks":[1,[]],"tags":[1,[]],"animate":[0,true],"theme":[0,"themeWhite"],"showSocialShareBlock":[0,false]}" client="load" opts="{"name":"HomePage","value":true}" await-children="">


Preparing for future pandemics


CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.


Find out more


Latest News


Latest News


See more


*Blog*
Chukwuemeka Oguanuo: My Fellowship at CEPI


Read more9 Jul 2026


*Blog*
Bundibugyo and the 100 Days Mission: Preparedness, Readiness and Response


Read more8 Jul 2026


*Blog*
New models of health-defence collaboration: a shared plan to achieve the 100 Days Mission


Read more8 Jul 2026


*News*
New experts appointed to CEPI’s Scientific Advisory Committee


Read more1 Jul 2026


*Blog*
The lab scientists banding together to test new outbreak-busting vaccines


Read more29 Jun 2026


*Explainer*
CEPI 3.0 explained: Platform technologies


Read more26 Jun 2026


*Statement*
CEPI statement: G7 Leaders' call for a coordinated response to the Bundibugyo ebola outbreak


Read more17 Jun 2026


*News*
U.S. Department of State commits $50 million to CEPI to fast-track Bundibugyo virus medical countermeasures


Read more12 Jun 2026


*Blog*
Biosecurity-by-design for CEPI’s Pandemic Preparedness Engine


Read more11 Jun 2026


*Impact story*
Outbreak ready, research ready: strengthening West Africa’s research ecosystem


Read more10 Jun 2026


Latest News


See more


We want to create a world in which epidemics and pandemics are no longer a threat to humanity.


CEPI is working to galvanise the development of new vaccines and other biologic countermeasures against diseases that could cause the next devastating epidemic or pandemic.


Our approach


Securing the Future


CEPI 3.0 – our 2027-2031 strategy – aims to transform the world’s ability to tackle epidemic and pandemic threats. Explore CEPI’s 3.0 Investment Case to see how we can #SecureTheFuture together.


Read more


Research and development


CEPI is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk.


Read more


Calls for Proposals


Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.


Read more


Process development and manufacturing


CEPI is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.


Read more


GraphicCircleDiagonalStripes


$12.5 trillion


IMF’s estimate cost of the COVID-19 pandemic to the global economy through 2024


GraphicCircleDotsWithBorder


Over 75


Number of CEPI-supported vaccine candidates and platform technologies.


GraphicCircleExpandingDots


470+


R&D partners collaborating with CEPI


Emerging infectious diseases affect us all. They do not respect borders.


A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity.


CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks.


We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem.


Find out more Arrow


Where to go next


Call for proposals - Bundibugyo Virus vaccinesRead moreCareersRead moreProcurement tendersRead morePriority pathogensRead more


Subscribe to our newsletter


Your email address


I agree to the terms and conditions


CEPI


**About**

- Our approach
- CEPI 2.0 and the 100 Days Mission
- Equitable access
- The CEPI team
- Board members & committees
- Investors
- Joint Coordination Group
- Scientific Advisory Committee
- Portfolio Strategy & Management Board
- Why we exist
- Documents library
- Careers

What we do



- Research & development
- Enabling science
- Vaccine technology
- Artificial Intelligence
- Biosecurity
- CEPI Technical Resources Hub
- Process development and manufacturing
- Priority pathogens
- Chikungunya
- Coronaviruses
- Disease X
- Filoviruses
- Lassa fever
- Mpox
- Nipah
- Rift Valley fever
- Our portfolio
- Policy briefing room

Partner with us



- Support CEPI
- Calls for proposals
- Procurement tenders
- Our coalition

Our impact



- Impact in focus
- Progress and results

News & stories



- News
- Stories
- How climate change increases pandemic risk
- The Viral Most Wanted
- Media resources

Legal



- Child Protection Statement
- Cookie Policy
- External Privacy Notice
- Modern Slavery, Human Trafficking and Human Rights Statement
- Navigating CEPI's Third Party Code
- Reporting concern
- Tackling Racism

Social



- Bluesky
- Facebook
- Linkedin
- X

©2026 CEPI. All rights reserved